SEC Comment Letter 0000000000-24-003474 to Clearmind Medicine Inc. (CMND)

Clearmind Medicine Inc.
Date: April 1, 2024 · CIK: 0001892500 · Accession: 0000000000-24-003474

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-41557

Date

April 1, 2024

Author

Alan Rootenberg

Form

UPLOAD

Company

Clearmind Medicine Inc.

Letter

United States securities and exchange commission logo April 1, 2024 Alan Rootenberg Chief Financial Officer Clearmind Medicine Inc. 101 – 1220 West 6th Avenue Vancouver, British Columbia Re:Clearmind Medicine Inc. Form 20-F for the fiscal year ended October 31, 2023 Filed January 29, 2024 File No. 001-41557 Dear Alan Rootenberg: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
April 1, 2024
Alan Rootenberg
Chief Financial Officer
Clearmind Medicine Inc.
101 – 1220 West 6th Avenue
Vancouver, British Columbia
Re:Clearmind Medicine Inc.
Form 20-F for the fiscal year ended October 31, 2023
Filed January 29, 2024
File No. 001-41557
Dear Alan Rootenberg:
            We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io